
New IPR policy retains access to cheap drugs
The HinduThe NDA government on Friday announced the long-pending, “all-encompassing” National Intellectual Property Rights Policy. Responding to queries about the policy approved by the Cabinet on Thursday night, Union Finance Minister Arun Jaitley said, “Our approach balances consideration of inventability, innovation and public health consideration.” Though the U.S. concerns include the “rejections” of patent applications for innovative pharmaceutical products due to “unpredictable” application of Section 3 of the Patents Act, Mr. Jaitley clarified that the policy will ensure that no changes are made in that Section and the patent-disabling Compulsory Licensing regime. Ensures safeguard for pharma industry The IPR policy approved by the Cabinet on Thursday night, comes in the backdrop of the US Trade Representative, in its annual Special 301 Report retaining India on the ‘Priority Watch List’ for “lack of sufficient measurable improvements to its IPR framework.” It also comes ahead of Prime Minister Narendra Modi’s U.S. visit in June. Committed to Doha In fact, the Policy states “India shall remain committed to the Doha Declaration on Trade Related IPR Agreement and Public Health.” It also says “India will continue to utilise the legislative space and flexibilities available in international treaties and the TRIPS Agreement.” These flexibilities include the sovereign right of countries to use provisions such as Section 3 and CLs for ensuring the availability of essential and life-saving drugs at affordable prices. To ensure strong and effective IPR laws, the Policy states India will engage constructively in the negotiation of international treaties and agreements in consultation with stakeholders.
History of this topic

Bharathiar University teams up with TIFAC, TNSCST to broad-base awareness on patents, copyrights and trademarks
The Hindu
Rule of law protects IPR and fuels innovation
China Daily
Rule of law protects IPR and fuels innovation
China Daily
India's Stance On IPRs, Pharma in FTA Will Fosters Growth Of Generic Drug Sector: GTRI
ABP News
Navigating Legal Challenges In The Development Of The Pharmaceutical Sector In India
ABP News
Suman Sahai | India has task cut out — to arrange waiver of IPR on green tech at G-20
Deccan Chronicle
Make in India: A strong IPR framework vital for the health care sector
Hindustan Times
India-U.K. FTA will tighten screws on generic drugs: Doctors Without Borders Médecins Sans Frontières
The Hindu
India needs stronger copyright and IP laws
Hindustan Times
Understanding India’s stand on IPR at the WTO
Live Mint
Explained | The Indian patent regime and its clash with the U.S. norms
The Hindu
每日一词∣知识产权保护 intellectual property rights protection
China Daily
每日一词∣知识产权保护 intellectual property rights protection
China Daily![[LIVE NOW] Webinar On "Revisiting The Access To Medicine Debate In The COVID-19 Era"-](/static/images/error.jpg)
[LIVE NOW] Webinar On "Revisiting The Access To Medicine Debate In The COVID-19 Era"-
Live Law
India, South Africa Are Seeking to Free Covid-19 Drugs and Vaccines from Patents and IPR. Here’s Why
News 18
Goyal calls for removing hurdles in access to medicines at affordable prices
India TV News
USTR’s move to keep India on IP watch list could hit covid-drug access
Live Mint
Govt floats draft guidelines for implementation of IPR policy in academic institutions
India Today
Road map to affordable medicines
The Hindu
Reward innovation
The Hindu
Innovate in India: The country cannot afford to wait any longer for a robust intellectual property rights regime
Firstpost
China reinforcing IP protection
China Daily
Tale Of Two IP Policies: A Few Remarks On IP Policies Of South Africa, India
Live Law
Tale Of Two IP Policies: A Few Remarks On IP Policies Of South Africa, India
Live Law
Create the framework
The Hindu
Call for Papers: International Conference on IP Law and Policy: A Device for Research & Development
Live Law
National IPR policy to promote creativity, innovation: DIPP
The Hindu
New IPR Policy
Live Law
NGOs urge PM to ‘resist pressure’ from U.S. on IPRs
The Hindu
National Intellectual Property Rights: patently a missed opportunity
The Hindu
All you need to know about the new IPR Policy
The Hindu
US Chamber of Commerce welcomes India’s IPR policy
The Hindu![Cabinet approves National Intellectual Property Rights Policy [Read the Full Text]](/static/images/error.jpg)
Cabinet approves National Intellectual Property Rights Policy [Read the Full Text]
Live Law
Government to unveil IPR policy in a fortnight
The Hindu
Defending India’s IPR
The Hindu
Patent pressures
The Hindu
US happy about Modi talk on intellectual property but keeps India in watch list
Firstpost
Modi government examining IPR issues: USTR
The Hindu
Experts come out against draft National IPR policy
The Hindu
IPR Think Tank submits first draft of National IPR Policy
Live Law
IPR Think Tank submits first draft of National IPR Policy
Live Law
Patented medicine and affordability
The Hindu
Think tank set up to draft national IPR policy
The Hindu
India says it won't participate in unilateral US investigation on IPR
Live Law
India says it won't participate in unilateral US investigation on IPR
Live Law
India likely to drag US to WTO if classified ‘Priority Country’
The Hindu
Developing countries call for easing IPR costs of clean technologies
The Hindu
India undermining intellectual property: Pfizer tells US lawmakers
Firstpost
US views on India's IPR protection not justified: Sharma
FirstpostDiscover Related



























!['Vidhi Pragati: National IP Moot Court Competition' By NLU Delhi In Collaboration With Department For Promotion Of Industry And Internal Trade [7th-9th Feb]](/static/images/error.jpg)

![RMLNLU Lucknow: Faculty Development Programme [9th -16th February]](/static/images/error.jpg)














![Round Table Discussions Of The South Asian Global Intellectual Property Summit, 2024 Sets A New Benchmark In Regional Collaboration [21st - 22nd December]](/static/images/error.jpg)